The Leprosy Mission Trust India, New Delhi, India.
Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
PLoS One. 2023 Oct 18;18(10):e0275763. doi: 10.1371/journal.pone.0275763. eCollection 2023.
People affected by leprosy are at increased risk of impairments and deformities from peripheral nerve damage. This mostly occurs if diagnosis and treatment is delayed and contributes to continued transmission within the community. Champa district of Chhattisgarh state in India is an endemic area with the highest national annual case detection and disability rates for leprosy. The Replicability Model is a system strengthening intervention implemented by the Leprosy Mission Trust India in Champa that aims to promote early diagnosis and treatment of leprosy, improve on-going management of the effects of leprosy and improve welfare for the people affected by leprosy. This protocol presents a plan to describe the overall implementation of the Replicability Model and describe the barriers and facilitators encountered in the process. We will also quantify the effect of the program on one of its key aims- early leprosy diagnosis.
The replicability model will be implemented over four years, and the work described in this protocol will be conducted in the same timeframe. We have two Work Packages (WPs). In WP1, we will conduct a process evaluation. This will include three methods i) observations of replicability model implementation teams' monthly meetings ii) key informant interviews (n = 10) and interviews with stakeholders (n = 30) iii) observations of key actors (n = 15). Our purpose is to describe the implementation process and identify barriers and facilitators to successful implementation. WP2 will be a quantitative study to track existing and new cases of leprosy using routinely collected data. If the intervention is successful, we expect to see an increase in cases (with a higher proportion detected at an early clinical stage) followed by a decrease in total cases.
This study will enable us to improve and disseminate the Replicability Model by identifying factors that promote success. It will also identify its effectiveness in fulfilling one of its aims: reducing the incidence of leprosy by finding and tracking cases at an earlier stage in the disease.
受麻风病影响的人因周围神经损伤而面临更高的残疾和畸形风险。如果诊断和治疗延迟,这种情况大多会发生,并导致社区内持续传播。印度恰蒂斯加尔邦的昌帕区是一个地方性流行地区,麻风病的年全国病例检出率和残疾率最高。复制模型是印度麻风病使命信托在昌帕实施的一项系统强化干预措施,旨在促进麻风病的早期诊断和治疗,改善麻风病的持续管理,并改善受麻风病影响的人的福利。本方案旨在描述复制模型的总体实施情况,并描述在实施过程中遇到的障碍和促进因素。我们还将量化该计划对其关键目标之一——早期麻风病诊断的影响。
复制模型将在四年内实施,本方案中描述的工作将在同一时间段内进行。我们有两个工作包(WP)。在 WP1 中,我们将进行过程评估。这将包括三种方法:i)观察复制模型实施团队的每月会议;ii)关键知情人访谈(n=10)和利益相关者访谈(n=30);iii)观察关键行为者(n=15)。我们的目的是描述实施过程,并确定成功实施的障碍和促进因素。WP2 将是一项使用常规收集的数据跟踪现有和新的麻风病病例的定量研究。如果干预措施成功,我们预计会看到病例增加(更高比例的病例在早期临床阶段被发现),随后总病例数减少。
这项研究将使我们能够通过确定促进成功的因素来改进和推广复制模型。它还将确定其在实现目标之一方面的有效性:通过更早地发现和跟踪病例来减少麻风病的发病率。